The most expensive medical certificate in the history of spaceflight cost a Japanese entrepreneur his ticket to orbit, his reputation, and two decades of litigation—yet still failed to reveal what really happened in the 72 hours before launch.
🚀 September 16, 2006, three days before the launch of Soyuz TMA-9, something unprecedented happened at the Baikonur Cosmodrome: a man in a spacesuit, who had passed six months of training and medical clearance, was pulled from the flight at the moment the rocket already stood on the pad. Daisuke Enomoto, a Japanese millionaire who had paid $21 million to Space Adventures for the right to become the fourth space tourist in history, never boarded. Instead, Anousheh Ansari—an Iranian-American entrepreneur who had trained as his backup—climbed into the spacecraft. Roscosmos delivered its verdict in a single phrase: "medical indications." No further explanation followed.
🔬 Enomoto had spent six months in Star City, enduring the centrifuge, the altitude chamber, training in the hydro lab, and hundreds of hours studying the spacecraft’s systems. The medical commission of the Institute of Biomedical Problems of the Russian Academy of Sciences (IMBP RAS) had cleared him for flight. His personal physician had publicly stated there were no contraindications. A day before launch, Enomoto gave interviews to journalists, spoke of his readiness for the mission, posed beside the rocket. But in the final moment, an invisible hand crossed it all out—and the $21 million paid in advance turned into the most expensive unused ticket in history. Roscosmos did not refund the money. Space Adventures claimed it had fulfilled its obligations in preparing him. Enomoto launched a legal war that dragged on for years, exposing details both sides would have preferred to keep buried.
💎 The official version only surfaced in court documents filed by Space Adventures in response to Enomoto’s lawsuit for a refund. The "medical reason" turned out to be chronic kidney stones—a diagnosis that, on its own, is not an absolute contraindication for spaceflight but requires strict monitoring and therapy. According to the company, Enomoto had failed to follow the prescribed treatment, ignored doctors’ recommendations, and concealed the worsening of his condition. Roscosmos, upon receiving data about the risk of renal colic in microgravity, made the decision to ground the tourist at the last possible moment—when there was no time left for additional examinations or therapy adjustments. In weightlessness, stones can shift and block the ureter, leading to acute pain, inability to urinate, and the need for emergency medical intervention, which would be difficult to provide aboard the ISS.
🩺 But Enomoto told a different story. In interviews, he claimed he had been misled: the real reason for his removal was his refusal to provide additional funds to Space Adventures after the contract had already been signed. According to the Japanese businessman, he had been promised the opportunity to conduct an extravehicular activity (EVA) for an extra fee, but the terms were so vaguely worded that he refused to sign new agreements. Of the $21 million, $14 million had been paid for the flight itself, and $7 million for the supposed EVA, which was never clearly defined in the contract. Enomoto alleged that the company had tried to extort more money from him, threatening to sabotage the mission, and when he refused, they found a convenient pretext in the form of "medical indications."
🧩 A third version, circulating in the shadows, hinted at a conflict between Enomoto and Roscosmos over commercial experiments. The Japanese businessman had planned to conduct a series of tests aboard the ISS related to his own business interests, but had not properly coordinated them with the Russian side. Roscosmos, fiercely protective of its control over the station’s scientific program, may have seen this as a protocol violation and used the medical file as a pressure tool. Neither side publicly commented on this version, but indirect evidence pointed to tension between Enomoto and the Russian overseers of the program long before the final stage of preparation.
📋 The contract between Space Adventures and the space tourists of that era was drafted in such a way that nearly all risks fell on the client’s shoulders. The conditions for refunds were extremely narrow: the company was only obligated to return the money if it failed to provide training or access to the flight due to its own fault. A tourist’s medical disqualification, even at the last moment, was not grounds for a refund. Enomoto contested this interpretation, arguing that he had not been informed of the real risks and had not been given the opportunity to rectify the situation. The legal battle became a war of interpretations: What counts as a medical contraindication? Who is responsible for monitoring the tourist’s health? How transparent should the terms of a $21 million contract be?
🌟 Anousheh Ansari, an Iranian-American entrepreneur, founder of Telecom Technologies, and sponsor of the Ansari X Prize—awarded for the first private manned spaceflight—was at Baikonur as the backup. She had undergone the same training as Enomoto but never expected to fly. September 16, 2006, her life changed in a matter of hours: Roscosmos announced the replacement, and Ansari was given three days for final checks and psychological adaptation. September 19, she boarded Soyuz TMA-9 alongside commander Mikhail Tyurin and flight engineer Michael López-Alegría. The flight lasted ten days, and Ansari became the first female space tourist, the first Iranian in orbit, and the fourth private space traveler in history.
🛰️ For Space Adventures, replacing Enomoto with Ansari was a reputation-saving move. The company, founded in 1998 and specializing in extreme tourism, had bet its future on space tourism as its flagship offering. The first tourist had been American millionaire Dennis Tito in 2001, followed by South African Mark Shuttleworth in 2002 and American Greg Olsen in 2005. Enomoto was supposed to be the fourth, but his failure could have undermined trust in the company. Ansari, already prepared and medically cleared, plugged the gap and allowed Space Adventures to save face with clients and partners.
⚖️ Enomoto filed a lawsuit to recover the $21 million, but the process dragged on for years. Court documents revealed details of contracts, medical protocols, and internal conflicts, but provided no definitive answer as to who was right. Space Adventures insisted that Enomoto had violated the training conditions by concealing health problems and ignoring treatment. Enomoto claimed the company had manipulated medical data to avoid a refund and replace him with a more convenient client. The court did not rule decisively in favor of either side, and the case was closed without all the circumstances being made public. The $21 million remained with Space Adventures.
🔍 Enomoto’s case exposed the central problem of early commercial spaceflight: the lack of transparent medical qualification standards for space tourists. Unlike professional cosmonauts, whose medical requirements had been refined over decades, tourists operated in a gray zone. Roscosmos had the right to ground someone at any moment, citing "medical indications," without any obligation to disclose details. Space Adventures, as the intermediary, bore no responsibility for Russian decisions but controlled information about the client’s health. This opacity created fertile ground for conflict: Who decides if a tourist is healthy? Who is liable if a problem is discovered at the last minute? Who pays for a canceled flight?
💊 Chronic kidney stones are not uncommon among middle-aged and older adults, but in the context of spaceflight, they become a ticking time bomb. In microgravity, fluids in the body redistribute, pressure in the urinary system changes, and the risk of stone movement increases. If a stone blocks the ureter, the tourist will be in acute pain, unable to function, and the crew will face the need for an emergency return to Earth or procedures they are not prepared for. Roscosmos, confronted with this risk three days before launch, made the only possible decision from a safety standpoint—but could not explain it publicly due to medical confidentiality.
🧪 Enomoto, by his own account, had not concealed the diagnosis but considered it manageable. He took medication, underwent examinations, followed recommendations. But Roscosmos’s medical commission, receiving data about his kidney condition at the last moment—possibly after an additional ultrasound or analysis—deemed the risk unacceptable. Why hadn’t this information surfaced earlier? Theories vary: either Enomoto had indeed concealed the worsening, or the Russian side had not conducted thorough enough checks in the early stages, or the data had been known but ignored until the final moment. Roscosmos remains silent, Space Adventures invokes medical confidentiality, and Enomoto gives evasive interviews.
📌 Anousheh Ansari returned from orbit on September 29, 2006, and became an icon of commercial spaceflight, inspiring a generation of entrepreneurs to dream of space. She founded a foundation supporting educational programs in space technology and continued investing in startups related to orbital exploration. Space Adventures conducted three more missions with space tourists: Charles Simonyi flew twice—in 2007 and 2009—Richard Garriott in 2008, and Guy Laliberté in 2009. After that, the program stalled until 2021, when Japanese billionaire Yusaku Maezawa flew to the ISS, paying for a twelve-day mission. The space tourism market shifted to new players: Blue Origin, Virgin Galactic, and SpaceX now offer suborbital and orbital flights under more transparent contracts, with clear medical standards and insurance guarantees.
📌 Daisuke Enomoto never made it to space, but his story changed the industry. After his legal battle with Space Adventures, companies involved in space tourism began detailing contracts, specifying refund conditions for medical disqualifications, and creating multi-stage systems for monitoring clients’ health. Today, prospective tourists undergo examinations early on, receive clear medical conclusions, and have the right to second opinions from independent physicians. Roscosmos, NASA, and private companies have developed common medical fitness standards for non-professional spaceflight participants—standards that did not exist in 2006.
📌 Enomoto’s $21 million was never returned, but his case became a precedent, protecting future clients from similar situations. In 2021, the Inspiration4 mission, organized by SpaceX, sent four non-professional astronauts into orbit, including Hayley Arceneaux—a cancer survivor with a titanium rod in her leg. Medical requirements were adapted to individual characteristics, risks were assessed in advance, and contracts were signed with full disclosure of terms. Enomoto remains in history as the man who paid the highest price for a lesson but received neither the stars nor justice in return—only a place in Roscosmos’s archives, which have maintained their silence for two decades.